Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Nov 9:13:1024124.
doi: 10.3389/fimmu.2022.1024124. eCollection 2022.

Analysis of macular structure in age-related cataract patients with different antibody levels of severe acute respiratory syndrome coronavirus-2 vaccine

Xiaochun Li  1   2 , Xiaoguang Cao  1 , Zhongting Pan  2 , Xinping Sun  3 , Yongzhen Bao  1
Affiliations

Analysis of macular structure in age-related cataract patients with different antibody levels of severe acute respiratory syndrome coronavirus-2 vaccine

Xiaochun Li et al. Front Immunol. .

Abstract

Objective: To analyze the macular structure of age-related cataract (ARC) patients with different antibody levels after COVID-19 vaccine injection, in order to obtain the effect of COVID-19 vaccine on the macular structure, and speculate whether the COVID-19 vaccine has adverse effects on the macular structure.

Methods: This retrospective study is conducted to analysis on the status of COVID-19 vaccine and the thickness of different layers at different positions in the macular area of ARC patients. In the age, sex and eye axial length matched population, in the un-injection, no-antibody, IgM and IgG positive groups after vaccination, the choroid, ganglion cell complex, nerve fiber layer and retinal thickness at different positions of ETDRS zoning in the macular area were discussed.

Results: A total of 164 patients (164 eyes) were included in the analysis. There were 63 males and 101 females. The average age was 65.99 ± 8.43 years. There was no significant difference in age and sex among the groups (p>0.05). The average axial length of 164 eyes was 23.56 ± 1.46mm, and no significant difference between the groups (p>0.05). Non parametric test and ANOVA test for the thickness of choroid, retina, ganglion cell complex and retinal nerve fiber layer in each division of ETDRS showed no significant difference in the four groups of un-injection, no-antibody, IgM and IgG (p>0.05). There was no correlation between the antibody concentration and the thickness of macular structure (p>0.05).

Conclusion: There was no significant difference in the thickness of choroid, retina, ganglion cell complex and retinal fiber layer in different macular areas after COVID-19 vaccine injection. There was no linear correlation between the thickness of choroid, retina, ganglion cell complex and retinal fiber layer and the antibody concentration produced after COVID-19 vaccine injection. It suggests that the injection of COVID-19 vaccine might have no significant effect on the macular structure of eye.

Keywords: COVID-19 vaccine; ETDRS zoning; antibody; macula; retina.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Similar articles

See all similar articles

References

    1. Brandão-de-Resende C, Diniz-Filho A, de Almeida Brito F, Vasconcelos-Santos D. SARS-CoV-2 and COVID-19 for the ophthalmologist. Clin Exp Ophthalmol (2021) 49:70–80. doi: 10.1111/ceo.13877 - DOI - PubMed
    1. Zeng B, Gao L, Zhou Q, Yu K, Sun F. Effectiveness of COVID-19 vaccines against SARS-CoV-2 variants of concern: a systematic review and meta-analysis. BMC Med (2022) 20:200. doi: 10.1186/s12916-022-02397-y - DOI - PMC - PubMed
    1. Hadj Hassine I. Covid-19 vaccines and variants of concern: A review. Rev Med Virol (2022) 32:e2313. doi: 10.1002/rmv.2313 - DOI - PMC - PubMed
    1. Zhang H, Du F, Cao X, Feng X, Zhang H, Wu Z, et al. . Clinical characteristics of coronavirus disease 2019 (COVID-19) in patients out of wuhan from China: a case control study. BMC Infect Dis (2021) 21:207. doi: 10.1186/s12879-021-05897-z - DOI - PMC - PubMed
    1. Galassi G, Rispoli V, Iori E, Ariatti A, Marchioni A. Coincidental onset of ocular myasthenia gravis following ChAdOx1 n-CoV-19 vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Israel Med Assoc J: IMAJ (2022) 24:9–10. - PubMed

Publication types